Trials / Completed
CompletedNCT00328393
Effect of Pioglitazone on Ambulatory Blood Pressure
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- University of Erlangen-Nürnberg Medical School · Academic / Other
- Sex
- Male
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The anti-diabetic pioglitazone has been found to reduce casual blood pressure. To date, no data are available looking at this effect in detail. Especially, ambulatory blood pressure has not yet been utilized to confirm the hypothesis that pioglitazone has blood pressure lowering effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pioglitazone | 45 mg 8 weeks |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2007-03-01
- Primary completion
- 2007-03-01
- Completion
- 2011-01-01
- First posted
- 2006-05-19
- Last updated
- 2012-07-10
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00328393. Inclusion in this directory is not an endorsement.